Loading...

Onward Medical N.V.

ONWD.BREURONEXT
Healthcare
Biotechnology
4.45
0.25(5.83%)

Onward Medical N.V. (ONWD.BR) Stock Competitors & Peer Comparison

See (ONWD.BR) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
ONWD.BR€4.45+5.83%188M-5.26-€0.80N/A
UCB.BR€177.90-0.56%33.9B32.57€5.47+0.67%
ARGX.BR€510.80+3.40%30.8B36.08€13.97N/A
TUB.BR€142.00-0.98%6.3B70.50€2.02+0.63%
ABVX.PA€57.20-1.89%3.6B-19.32-€2.95N/A
GLPG.AS€28.54+11.83%1.8B-6.21-€4.38N/A
ALNEV.PA€1.52-7.59%805M-0.01-€221.36N/A
GTBP.PA€280.50+0.00%626.7M-4.10-€68.39N/A
PHARM.AS€0.87+0.52%589.9M-43.05-€0.02N/A
MEDCL.PA€17.19+2.26%566M-15.70-€1.09N/A
Showing 1 to 10 of 69 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

ONWD.BR vs UCB.BR Comparison July 2025

ONWD.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ONWD.BR stands at 188M. In comparison, UCB.BR has a market cap of 33.9B. Regarding current trading prices, ONWD.BR is priced at €4.45, while UCB.BR trades at €177.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ONWD.BR currently has a P/E ratio of -5.26, whereas UCB.BR's P/E ratio is 32.57. In terms of profitability, ONWD.BR's ROE is -1.08%, compared to UCB.BR's ROE of +0.11%. Regarding short-term risk, ONWD.BR is more volatile compared to UCB.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ONWD.BR.Check UCB.BR's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;